|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 22702657.2 (espacenet) (Federated) (European Patent Register), 20220125 | | Patent/reg. no. and date | DK/EP 4281046, 20250910 | | Publication date | 20231129 | | Priority no. and date | EP 21153332, 20210125 | | EP pub. no. and date |
EP 4281046 20231129 | | Effective date | | | Applicant/owner | LDN Pharma Limited, 45 Gresham Street
London EC2V 7BG, GB | | Applicant ref. no. | | | Inventor | HOOD, Francis,
London EC2R 6AY, GB | | Representative | | | Opponent | | | IPC Class | A61K 31/485 (2006.01) , A61K 31/593 (2006.01) , A61K 9/19 (2006.01) , A61K 9/20 (2006.01) , A61K 9/24 (2006.01) , A61P 35/00 (2006.01) | | Title | NALTREXONE COMPOSITIONS | | Int. application no. | EP2022051619 | | Int. publication no. | WO2022157385 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
